Can Ozempic and Wegovy help with anxiety and depression?

Yes, new research suggests that medications like Ozempic and Wegovy, containing semaglutide, are associated with a lower risk of worsening depression and anxiety.

What is semaglutide and what are its potential benefits?

Semaglutide is a GLP-1 receptor agonist found in Ozempic and Wegovy, and it is linked to a reduced risk of worsening depression, anxiety, and substance abuse.

Are there risks associated with GLP-1 agonists during pregnancy?

Danish research indicates that GLP-1 receptor agonists may heighten the risk of pre-term birth when used for diabetes treatment, but not when used for weight management.

Home / Health / Ozempic, Wegovy May Ease Anxiety, Depression

Ozempic, Wegovy May Ease Anxiety, Depression

19 Mar

•

Summary

Semaglutide linked to 44% reduced depression risk.
Liraglutide also showed lower depression risk.
Pregnancy risks differ based on diabetes or weight loss use.

Ozempic, Wegovy May Ease Anxiety, Depression

Medications such as Ozempic and Wegovy, containing the active ingredient semaglutide, are showing potential benefits for mental health, according to new international research. These drugs, classified as GLP-1 receptor agonists, were analyzed for their impact on anxiety and depression.

A study drawing on Swedish health registries examined over 95,000 patients. It found that semaglutide was associated with a 44% reduced risk of worsening depression and a 38% reduced risk of anxiety. Liraglutide, another GLP-1 agonist, also showed a lower risk of worsening depression.

Researchers suggest semaglutide and liraglutide could be effective dual therapeutic options for conditions co-occurring with diabetes and obesity. Potential explanations for these effects range from weight loss and improved body image to direct neurobiological mechanisms.